SecBot SecBot
SECBOTREPLAY Home › Report › XERS

XERS · Director Marla Persky filed a Form 144 notice of intent to sell 15,500…

Xeris Biopharma Holdings, Inc. · 144 filed Jun 3, 2026 at 16:25 ET

At the news

NEUTRALIMPACT 2/10

144 filed Jun 3, 2026 at 16:25 ET

Director Marla Persky filed a Form 144 notice of intent to sell 15,500 shares of XERS common stock, with an estimated aggregate market value of $93,000. The shares were acquired via restricted stock units on June 3, 2026. This is a small, routine sale by a non-executive director, the dollar value is negligible relative to the company's $1.1B market cap and represents no material insider signal.

  • Filer: Director Marla Persky (non-executive board member)
  • Shares to be sold: 15,500 shares of common stock
  • Estimated value: $93,000 (based on filing date price of ~$6.00/share)
  • Shares acquired via restricted stock units on June 3, 2026

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access